These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 14720455)

  • 41. Alcoholic liver disease: pathogenesis and new therapeutic targets.
    Gao B; Bataller R
    Gastroenterology; 2011 Nov; 141(5):1572-85. PubMed ID: 21920463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity.
    Naveau S; Emilie D; Balian A; Grangeot-Keros L; Borotto E; Portier A; Giraud V; Capron F; Galanaud P; Chaput JC
    J Hepatol; 1998 May; 28(5):778-84. PubMed ID: 9625312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.
    Nagata K; Suzuki H; Sakaguchi S
    J Toxicol Sci; 2007 Dec; 32(5):453-68. PubMed ID: 18198478
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of iron in alcoholic liver disease: introduction and summary of the symposium.
    Purohit V; Russo D; Salin M
    Alcohol; 2003 Jun; 30(2):93-7. PubMed ID: 12957291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Alcoholic liver disease--established treatment and new therapeutic approaches].
    Stickel F; Seitz HK; Hahn EG; Schuppan D
    Z Gastroenterol; 2003 Apr; 41(4):333-42. PubMed ID: 12695940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease.
    Lieber CS; Weiss DG; Groszmann R; Paronetto F; Schenker S;
    Alcohol Clin Exp Res; 2003 Nov; 27(11):1765-72. PubMed ID: 14634492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathogenesis and management of alcoholic liver injury.
    Pár A
    Acta Physiol Hung; 1992; 80(1-4):325-50. PubMed ID: 1345200
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New trends in the therapy of alcoholic hepatic diseases].
    Tarantino G; Di Bernardo C; Vitaglione R; Cambri S
    Clin Ter; 1984 May; 109(3):243-58. PubMed ID: 6203679
    [No Abstract]   [Full Text] [Related]  

  • 49. Alcoholic steatohepatitis.
    Stickel F; Seitz HK
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):683-93. PubMed ID: 20955970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dilinoleoylphosphatidylcholine selectively modulates lipopolysaccharide-induced Kupffer cell activation.
    Oneta CM; Mak KM; Lieber CS
    J Lab Clin Med; 1999 Nov; 134(5):466-70. PubMed ID: 10560939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New concepts in the pathogenesis of alcoholic liver disease.
    Albano E
    Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):749-59. PubMed ID: 19090736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polyenylphosphatidylcholine protects against alcohol but not iron-induced oxidative stress in the liver.
    Aleynik SI; Leo MA; Aleynik MK; Lieber CS
    Alcohol Clin Exp Res; 2000 Feb; 24(2):196-206. PubMed ID: 10698372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognosis and treatment of patients with acute alcoholic hepatitis.
    Papastergiou V; Burroughs AK; Tsochatzis EA
    Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):471-86. PubMed ID: 24716632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alcohol, oxidative stress and free radical damage.
    Albano E
    Proc Nutr Soc; 2006 Aug; 65(3):278-90. PubMed ID: 16923312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dilinoleoylphosphatidylcholine is the active antioxidant of polyenylphosphatidylcholine.
    Aleynik SI; Leo MA; Takeshige U; Aleynik MK; Lieber CS
    J Investig Med; 1999 Nov; 47(9):507-12. PubMed ID: 10572382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The knowns and unknowns of treatment for alcoholic hepatitis.
    Sehrawat TS; Liu M; Shah VH
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):494-506. PubMed ID: 32277902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of alcoholic liver disease.
    Saunders JB
    Baillieres Clin Gastroenterol; 1989 Jan; 3(1):39-65. PubMed ID: 2655753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. S-adenosyl-L-methionine for alcoholic liver diseases.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2001; (4):CD002235. PubMed ID: 11687153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ethanol metabolism, cirrhosis and alcoholism.
    Lieber CS
    Clin Chim Acta; 1997 Jan; 257(1):59-84. PubMed ID: 9028626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Medical Treatment of Alcoholic Liver Disease].
    Song DS
    Korean J Gastroenterol; 2020 Aug; 76(2):65-70. PubMed ID: 32839368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.